Background: This study focuses on analyzing stigmasterol, a key compound found in Streblus asper lour., in both stem bark and small branches, and investigates its potential as an alternative source. Objective: To analyze the stigmasterol content in both stem bark and small branches of S. asper through High-Performance Liquid Chromatography (HPLC) techniques. In addition, molecular docking studies are conducted to assess the interaction of stigmasterol with selected anticancer and anti-diabetic target proteins. Materials and Methods: The study involved the comparative analysis of stigmasterol content in stem bark and small branches using HPLC techniques. Molecular docking simulations were performed to evaluate the binding affinity of stigmasterol with target proteins associated with anticancer and anti-diabetic activities. Results: HPLC analysis revealed stigmasterol content of 0.13298% in stem bark and 0.0373% in small branches. Molecular docking simulations demonstrated favorable binding energies (−9.0, −12.2, −9.8, −10.5, and −9.5 kcal/mol) of stigmasterol with selected target proteins. Conclusion: Both stem bark and small branches of S. asper contain stigmasterol, indicating their potential as a source of this compound with promising in silico anticancer and anti-diabetic activity. Utilizing small branches could offer a sustainable alternative while conserving the plant species and its ecological balance. Further validation through in vitro and in vivo studies is warranted to explore the therapeutic potential of stigmasterol fully.